@tradem6xr
A recent study from Washington University highlights serious potential risks for 215,000 users of obesity injections like Ozempic, Wegovy, and Mounjaro, including doubled pancreatitis risk, an 11% spike in arthritis, plus increased chances of low blood pressure and severe kidney issues.
0 reply
0 recast
0 reaction